CSBR

Champions Oncology, Inc. (CSBR) ESG Analysis Analysis (2026)

Invetso Score: 6.7/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 4.8 (Moderate)

Champions Oncology’s environmental risk profile is moderate, with a low direct footprint but limited disclosure and no formal climate or sustainability strategy. The absence of transparent reporting and targets is a gap versus best-in-class peers.

Social

Score:

Champions Oncology demonstrates strong social performance through R&D investment and financial stability, but lacks transparency on diversity and inclusion, which could become a competitive gap as stakeholder expectations rise.

Governance

Score:

Governance practices are generally sound, with experienced leadership and prudent capital management. However, limited disclosure on board structure and independence constrains a higher score relative to best-practice peers.

Overall Score

Score:

Champions Oncology’s ESG profile is strong overall, driven by robust social performance and sound governance, though environmental and governance disclosures lag sector leaders. The company’s focus on R&D and financial stability supports long-term value, but greater transparency on environmental and board practices would further strengthen its ESG standing.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Champions Oncology, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →